Objective analysis of cancer stem cell marker expression using immunohistochemistry.

Area of Science:

• Oncology
• Pathology
• Biomedical Imaging

Background:

• Immunohistochemical analysis is often subjective, leading to inconsistent reporting of cancer stem cell marker expression.
• Digital analysis offers a potential solution for more objective and reproducible quantification.

Purpose of the Study:

• To compare tissue scoring with digital analysis for five cancer stem cell markers (ALDH1, CD44v6, CD133, Lgr5, SOX2).
• To assess the impact of region selection and quantification methods on results in colon cancer.
• To evaluate the concordance of different digital analysis annotation methods.

Main Methods:

• Analysis of immunohistochemical staining for ALDH1, CD44v6, CD133, Lgr5, and SOX2.
• Comparison of manual tissue scoring with three digital analysis methods using annotated tissue regions.
• Inclusion of tumour and normal mucosa samples from 10 stage II colon cancer patients.

Main Results:

• Digital analysis methods showed overall concordant results, contrasting with subjective tissue scoring.
• Discordant results were observed for SOX2 in normal tissue and CD133 in both tumour and normal tissue.
• Discrepancies were attributed to variations in the analyzed tissue regions.

Conclusions:

• Digital image analysis provides more consistent results for cancer stem cell marker quantification than traditional tissue scoring.
• The choice of quantification method and the selection of analysis regions significantly impact study outcomes.
• Standardizing these parameters is essential for ensuring reproducible and reliable reporting in cancer research.